DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Glimepiride; pioglitazone hydrochlorideis the generic ingredient in two branded drugs marketed by Takeda Pharms Usa and Sandoz, and is included in two NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
Glimepiride; pioglitazone hydrochloride has fifty-nine patent family members in thirty countries.
There are sixteen drug master file entries for glimepiride; pioglitazone hydrochloride. Three suppliers are listed for this compound.
Summary for GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
|Drug Master File Entries:||16|
|Suppliers / Packagers:||3|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE|
|DailyMed Link:||GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE at DailyMed|
Recent Clinical Trials for GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Azienda Ospedaliera di Padova||Phase 4|
|University of Padova||Phase 4|
Recent Litigation for GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
Identify potential future generic entrants
District Court Litigation
|Takeda Pharmaceutical Company Limited v. Hetero Drugs Limited||2011-11-16|
|Takeda Pharmaceutical Company Limited v. Accord Healthcare, Inc.||2011-09-12|
|Takeda Pharmaceutical Company Limited v. Macleods Pharmaceuticals Limited||2011-05-06|
Pharmacology for GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE
|Drug Class||Sulfonylurea |
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
|Mechanism of Action||Peroxisome Proliferator-activated Receptor Activity |
|Country||Patent Number||Estimated Expiration|
|European Patent Office||1677792||Start Trial|
|South Korea||20060061383||Start Trial|
|>Country||>Patent Number||>Estimated Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.